Sample preparation and storage can change: Arsenic speciation in human urine

Clinical Chemistry

Volumn 45, Issue 11, 1999, Pages 1988-1997

  Feldmann, Jörg ^a   Lai, Vivian W M ^b   Cullen, William R ^b   Ma, Mingsheng ^c   Lu, Xiufen ^c   Le, X Chris ^c,d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Faculty of Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; ARSENOBETAINE; CACODYLIC ACID; METHANEARSONIC ACID;

ARTICLE; CHEMICAL ANALYSIS; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW TEMPERATURE; MASS SPECTROMETRY; STORAGE; URINALYSIS;

EID: 0032737803     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.11.1988     Document Type: Article

References (54)

1. 1. Chappell WR, Abernathy CO, Cothern CR, eds. Arsenic: exposure and health effects, Northwood, UK: Sci Technol Lett, 1994:318 pp.
2. 2. Abernathy CO, Calderon RL, Chappell WR, eds. Arsenic, exposure and health effects. London: Chapman & Hall, 1997:429 pp.
3. 3. Buchet JP, Lauwerys R. Evaluation of exposure to inorganic arsenic in man. In: Facchetti S, ed. Analytical techniques for heavy metals in biological fluids. Amsterdam: Elsevier, 1983:75-90.
4. 4. Vahter M. Species differences in the metabolism of arsenic compounds. Appl Organomet Chem 1994;8:175-82.
5. 5. Le XC, Cullen WR, Reimer KJ. Human urinary arsenic excretion following one-time ingestion of arsenosugars present in seaweed and arsenobetaine present in crab and shrimp. Clin Chem 1994; 40:617-25.
6. 6. Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health 1981; 48:111-8.
7. 7. Vahter M. Environmental and occupational exposure to inorganic arsenic. Acta Pharmacol Toxicol 1986;59:31-4.
8. 8. Vahter M. What are the chemical forms of arsenic in urine, and what can they tell us about exposure? Clin Chem 1994;40:679-80.
9. 9. Vahter M. Metabolism of arsenic. In: Fowler BA, ed. Biological and environmental effects of arsenic. Amsterdam: Elsevier, 1983: 171-98.
10. 10. Buchet JP, Lauwerys R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int Arch Occup Environ Health 1981;48:71-9.
11. 11. Aposhian HV. Biochemical toxicology of arsenic. Rev Biochem Toxicol 1989;10:265-99.
12. 12. Styblo M, Delnomdedieu M, Thomas DJ. Biological mechanisms and toxicological consequences of the methylation of arsenic. In: Goyer RA, Cherian G, eds. Toxicology of metals - biochemical aspects. Handbook of experimental pharmacology. Berlin: Springer-Verlag, 1995:407-33.
13. 13. Tezuka M, Hanioka K, Yamanaka K, Okada S. Gene damage induced in human alveolar type II (L-132) cells by exposure to dimethylarsinic acid. Biochem Biophys Res Commun 1993;191: 1178-83.
14. 14. Yamanaka K, Okada S. Induction of lung specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ Health Perspect 1994;102:37-40.
15. 15. Ochi T, Nakajima F, Sakurai T, Kaise T, Oya-Ohya Y. Dimethylarsinic acid causes apoptosis in HL-60 cells via interaction with glutathione. Arch Toxicol 1996;70:815-21.
16. 16. Wanibuchi H, Yamamoto S, Chen H, Yoshida K, Endo G, Hori T, Fukushima S. Promoting effects of dimethylarsinic acid on N-butyl-N (4-hydroxybutyl)nitrosamine induced urinary bladder carcinogenesis in rats. Carcinogenesis 1996;17:2435-9.
17. 17. Brown JL, Kitchin KT, George M. Dimethylarsinic acid treatment alters six different rat biochemical parameters: relevance to arsenic carcinogenesis. Teratog Carcinog Mutagen 1997;17:71-84.
18. 18. Zhao CQ, Young M, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A 1997;94:10907-12.
19. 19. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 1997;386:263-77.
20. 20. Hopenhayn-Rich C, Smith AH, Goeden HM. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res 1993;60:161-77.
21. 21. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 1996;104: 620-8.
22. 22. Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect 1996;104:1200-7.
23. 23. Foà V, Colombi A, Maroni M, Burrati M, Calzaferri G. The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci Total Environ 1984;34:241-59.
24. 24. Kalman DA, Hughes J, van Belle G, Burbacher T, Bolgiano D, Coble K, et al. The effect of variable environmental arsenic contamination on urinary concentrations of arsenic species. Environ Health Perspect 1990;89:145-51.
25. 25. Yamauchi H, Takahashi K, Mashiko M, Saitoh J, Yamamura Y. Intake of different chemical species of dietary arsenic by the Japanese, and their blood and urinary arsenic levels. Appl Organomet Chem 1992;6:383-8.
26. 26. Styblo M, Yamauchi H, Thomas DJ. Comparative in vitro methylation of trivalent and pentavalent arsenicals. Toxicol Appl Pharmacol 1995;135:172-8.
27. 27. Hakala E, Pyy L. Assessment of exposure to inorganic arsenic by determining the arsenic species excreted in urine. Toxicol Lett 1995;77:249-58.
28. 28. Lin TH, Huang YL. Chemical speciation of arsenic in urine of patients with blackfoot disease. Biol Trace Elem Res 1995;48: 251-61.
29. 29. Buchet JP, Lison D, Ruggeri M, Foa V, Elia G. Assessment of exposure to inorganic arsenic, a human carcinogen, due to the consumption of seafood. Arch Toxicol 1996;70:773-8.
30. 30. Yager JW, Hicks JB, Fabianova E. Airborne arsenic and urinary excretion of arsenic metabolites during boiler cleaning operations in a Slovak coal-fired power plant. Environ Health Perspect 1997; 105:836-42.
31. 31. Del Razo LM, Garcia-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, et al. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol 1997;71:211-7.
32. 32. Ng JC, Johnson D, Imray P, Chiswell B, Moore MR. Speciation of arsenic metabolites in the urine of occupational workers and experimental rats using an optimised hydride cold-trapping method. Analyst 1998;123:929-33.
33. 33. Kavanagh P, Farago ME, Thornton I, Goessler W, Kuehnelt D, Schlagenhaufen C, Irgolic KJ. Urinary arsenic species in Devon and Cornwall residents, UK. A pilot study. Analyst 1998;123: 27-9.
34. 34. Vahter M, Concha G, Nermell B, Nilsson R, Dulout F, Natarajan AT. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol Environ Toxicol Pharmacol 1995;293: 455-62.
35. 35. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 1998;44:185-90.
36. 36. Schaller KH, Fleischer M, Angerer J, Lewalter J. Arsenic determination in urine. In: Angerer J, Schaller KH, eds. Analyses of hazardous substances in biological materials. Weinheim, Germany: VCH Verlag, 1991:69-80.
37. 37. Larsen EH, Pritzl G, Hansen SH. Speciation of eight arsenic compounds in human urine by high-performance liquid chromatography with inductively coupled plasma mass spectrometric detection using antimonate for internal chromatographic standardization. J Anal Atom Spectrom 1993;8:557-63.
38. 38. Palacios MA, Gomez M, Camara C, Lopez MA. Stability studies of arsenate, monomethylarsonate, dimethylarsinate, arsenobetaine and arsenocholine in deionized water, urine and clean-up dry residue from urine samples and determination by liquid chromatography with microwave-assisted oxidation-hydride generation atomic absorption spectrometric detection. Anal Chim Acta 1997; 340:209-20.
39. 39. Edmonds JS, Francesconi KA, Cannon JR, Raston CL, Skelton BW, White A. Isolation, crystal structure and synthesis of arsenobetaine, the arsenical constituent of the lobster Panulirus longipes cygnus george. Tetrahedron Lett 1977;18:1543-6.
40. 40. Calderon R, Hudgens EE, Le XC, Schreinemachers DM, Thomas, DJ. Excretion of arsenic in urine as a function of arsenic exposure in drinking water. Environ Health Perspect 1999;107:663-7.
41. 41. Le XC, Cullen WR, Reimer K. Speciation of arsenic compounds in some marine organisms. Environ Sci Technol 1994;28:1598-604.
42. 42. Le XC, Li X-F, Lai V, Ma M, Yalcin S, Feldmann J. Simultaneous speciation of selenium and arsenic using elevated temperature liquid chromatography separation with inductively coupled plasma mass spectrometry detection. Spectrochim Acta Part B At Spectrosc 1998;53:899-909.
43. 43. Le XC, Ma M. Short-column liquid chromatography with hydride generation atomic fluorescence detection for the speciation of arsenic. Anal Chem 1998;70:1926-33.
44. 44. Ma M, Le XC. Effect of arsenosugar ingestion on urinary arsenic speciation. Clin Chem 1998;44:539-50.
45. 45. Lynn B, Hugo WB. Chemical disinfectants, antiseptics and preservatives. In: Hugo WB, Russell AD, eds. Pharmaceutical microbiology, 3rd ed. London: Blackwell Scientific Publications, 1983:201-36.
46. 46. Zheng J, Goessler W, Kosmus W. Speciation of arsenic compounds by coupling high-performance liquid chromatography with inductively coupled plasma mass spectrometry. Mikrochim Acta 1998;130:71-9.
47. 47. Goessler W, Kuehnelt D, Irgolic KJ. Determination of arsenic compounds in human urine. In: Abernathy CO, Calderon RL, Chappell WR, eds. Arsenic: exposure and health effects. London: Chapman and Hall, 1997:33-44.
48. 48. Ritsema R, Dukan L, Roig T, Navarro I, van Leeuwen W, Oliveira N, et al. Speciation of arsenic compounds in urine by LC-ICPMS. Appl Organomet Chem 1998;12:591-9.
49. 49. Crecelius E, Yager J. Intercomparison of analytical methods for arsenic speciation in human urine. Environ Health Perspect 1997; 105:650-3.
50. 50. Pergantis SA, Winnik W, Betowski D. Determination of ten organoarsenic compounds using microbore high-performance liquid chromatography coupled with electrospray mass spectrometry mass spectrometry. J Anal Atom Spectrom 1997;12:531-6.
51. 51. Heitkemper D, Creed J, Caruso J. Speciation of arsenic in urine using high-performance liquid-chromatography with inductively coupled plasma mass-spectrometric detection. J Anal Atom Spectrom 1989;4:279-84.
52. 52. Sheppard BS, Shen WL, Caruso JA, Heitkemper DT, Fricke FL. Elimination of the argon chloride interference on arsenic speciation in inductively coupled plasma mass-spectrometry using ion chromatography. J Anal Atom Spectrom 1990;6:431-5.
53. 53. Story WC, Caruso JA, Heitkemper DT, Perkins L. Elimination of the chloride interference on the determination of arsenic using hydride generation inductively coupled plasma mass-spectrometry. J Chromatogr Sci 1992;30:427-32.
54. 54. Ding H, Wang JS, Dorsey JG, Caruso JA. Arsenic speciation by micellar liquid-chromatography with inductively-coupled plasmamass spectrometric detection. J Chromatogr A 1995;694:425-31.